RB

Ravi Bala Goel

Active Director Director DIN 00668417
DIN 00668417 First appointment Feb 1976 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 1976
Shareholding value Locked Premium profile

About Ravi Bala Goel

Ravi Bala Goel has 50 years in corporate governance. Holds Director role. Currently with 1 company, including Aarge Drugs Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 00668417
Primary Designation Director
First Appointment 06 Feb 1976
Oldest Company Age 50 yrs

Current companies

Company Designation Appointment Founded Status
Aarge Drugs Pvt Ltd U24231HP1976PTC003625
Director 06 Feb 1976 1976 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aarge Drugs Pvt Ltd
Premium access

Shareholding and investment profile for Ravi Bala Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Bala Goel

Ravi Bala Goel has 50 years in corporate governance. Holds Director role. Currently with 1 company, including Aarge Drugs Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

Ravi Bala Goel is associated with 1 company as Director.

Ravi Bala Goel has expertise in General Business.

Ravi Bala Goel has 50 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available